
Sheltering in place has pushed virtual health care into the mainstream, making us wonder if we’ll ever go back to waiting rooms
via Is COVID-19 the Tipping Point for Telemedicine? — Science | Smithsonian Magazine

Sheltering in place has pushed virtual health care into the mainstream, making us wonder if we’ll ever go back to waiting rooms
via Is COVID-19 the Tipping Point for Telemedicine? — Science | Smithsonian Magazine
Unlike the currently used molecular test that uses oral swab samples, the antibody test developed by Duke-NUS Medical School has several advantages — it can detect past infection in people who have now recovered, it relies on blood samples, and can identify asymptomatic cases. Using an antibody test developed by the Duke-NUS Medical School that […]
via Singapore develops antibody test to detect novel coronavirus infection — Science Chronicle
On February 20, China once again changed the case definition in Hubei province. All clinically confirmed cases will now be classified under suspected cases. Only molecular test positives will be labelled as confirmed. On February 12, the number of new COVID-19 cases reported from mainland China witnessed the biggest increase for a given day when […]
via COVID-19: China once again changes case definition in Hubei province — Science Chronicle
Hmm…
As of October 22, 2019, a total of 1,604 cases of EVALI, including 34 deaths, were reported to CDC. Based on data collected as of October 15, 2019, use of tetrahydrocannabinol (THC)-containing products in the 3 months preceding symptom onset was reported by 86% of patients. The median age of EVALI patients who survived was 23 years, and the median age of EVALI patients who died was 45 years.
The skeptical cardiologist has been evaluating a demo version of AliveCor’s new KardiaMobile 6L. I have been a huge advocate of Kardia’s single lead ECG and use it with great success in dozens of my afib patients. I’ve written about how this personal ECG monitoring empowers patients and providers and is a crucial component of…
Thanks Doctor for the ECG history lesson and for sharing your insights.
And congratulations on the Stanley Cup!
Go to the following link for a list of SGLT2 Inhibitors.
An Update on SGLT2 Inhibitors for the Treatment of Diabetes Mellitus
Fournier Gangrene does not sound like a pleasant disease.
Many thanks to Dr. P for reminding me to check and see what Dr. Attia has been up to lately.
Thank you Dr. Pearson.
Today’s early morning highlights from the major news organizations.
- Severe autoimmune diabetes (formerly type 1 diabetes): affected 6% of patients in the derivation cohort; characteristics include early-onset disease, relatively low BMI, and GADA-positive
- Severe insulin-deficient diabetes: 18% of patients; GADA-negative but similar to cluster 1; lowest HOMA2-B scores
- Severe insulin-resistant diabetes: 15%; higher HOMA2-IR scores
- Mild obesity-related diabetes: 22%; obese, but not insulin resistant
- Mild age-related diabetes: 39%; older than other clusters, but largely similar to cluster 4
Quoted from NEJM Journal Watch.
You must be logged in to post a comment.